A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states

NMR in Biomedicine

Volumn 24, Issue 3, 2011, Pages 231-237

  Wylezinska, Marzena ^a   Cobbold, Jeremy F L ^a   Fitzpatrick, Julie ^a   Mcphail, Mark J W ^a   Crossey, Mary M E ^a   Thomas, Howard C ^a   Hajnal, Joseph V ^a   Vennart, William ^b   Cox, I Jane ^a   Taylor Robinson, Simon D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Field strength comparison; Liver; MRS

Indexed keywords

CHEMICAL-SHIFT DISPERSION; CHRONIC LIVER DISEASE; FIELD STRENGTHS; FOCUS OF ATTENTION; IN-VIVO; LINE BROADENING; MAGNETIC FIELD STRENGTHS; MR SCANNERS; MR SIGNALS; MRS; MULTI-CENTRE STUDY; NUCLEAR OVERHAUSER EFFECTS; PAIRWISE TESTING; PHOSPHODIESTERS; PHOSPHOLIPID BILAYER; PROTON DECOUPLING; SIGNAL TO NOISE;

ESTERS; MAGNETIC FIELD EFFECTS; PHOSPHOLIPIDS; PROTONS; RESONANCE; SIGNAL TO NOISE RATIO;

LIVER;

PHOSPHOLIPID;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTERMETHOD COMPARISON; MAGNETIC FIELD; MALE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO;

ADULT; FEMALE; HUMANS; LIVER; LIVER DISEASES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHORUS ISOTOPES;

EID: 79952663216     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1578     Document Type: Article

References (25)

1. Cox IJ. Development and applications of in vivo clinical magnetic resonance spectroscopy. Progr. Biophys. Mol. Biol. 1996; 65: 45-81.
2. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T-1, T-2 relaxation and magnetization transfer in tissue at3T. Magn. Reson. Med. 2005; 54: 507-512.
3. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla - a comparative study. Invest. Radiol. 2007; 42: 449-459.
4. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn. Reson. Med. 2001; 45: 765-769.
5. Kim JH, Chang KH, Na DG, Song IC, Kim SJ, Kwon BJ, Han MH. Comparison of 1.5T and 3T H-1 MR spectroscopy for human brain tumors. Kor. J. Radiol. 2006; 7: 156-161.
6. Taylor-Robinson SD, Sargentoni J, Bell JD, Saeed N, Changani KK, Davidson BR, Rolles K, Burroughs AK, Hodgson HJF, Foster CS, Cox IJ. In vivo and in vitro hepatic P-31 magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver, 1997; 17: 198-209.
7. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in-vivo hepatic P-31 magnetic-resonance spectroscopy in cirrhosis - biochemical basis of spectral appearances. Hepatology, 1995; 21: 417-427.
8. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992; 5(5): 226-233.
9. Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo YT, Goldin RD, Taylor-Robinson SD. P-31 MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease Am. J. Roentgenol. 2007; 189: 819-823.
10. 31P MR spectroscopy to histology in chronic hepatitis. C Hepatology. 2003; 37(4): 788-794.
11. Bell JD, Cox IJ, Sargentoni J, Peden CJ, Menon DK, Foster CS, Watanapa P, Iles RA, Urenjak J. A P-31 and H-1-NMR investigation in-vitro of normal and abnormal human liver. Biochim. Biophys. Acta, 1993; 1225: 71-77.
12. Li CW, Negendank WG, Murphy-Boesch J, Padavic-Shaller K, Brown TR. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced P-31 NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed. 1996; 9: 141-155.
13. Barker PB, Golay X, Artemov D, Ouwerkerk R, Smith MA, Shaka AJ. Broadband proton decoupling for in vivo brain spectroscopy in humans Magn. Reson. Med. 2001; 45: 226-232.
14. Bachert P, Bellemann ME, Layer G, Koch T, Semmler W, Lorenz WJ. In vivo H-1, P-31-(H-1) and C-13-(H-1) magnetic-resonance spectroscopy of malignant histiocytoma and skeletal-muscle tissue in man. NMR Biomed. 1992; 5: 161-170.
15. Negendank W, Li CW, Shaller KP, MurphyBoesch J, Brown TR. Phospholipid metabolites in H-1-decoupled P-31 MRS in vivo in human cancer: implications for experimental models and clinical studies. Anticancer Res. 1996; 16: 1539-1544.
16. Vansluis R, Payne GS, Leach MO. Increased NOE enhancement in H-1 decoupled P-31 MRS 5. Magn. Reson. Med. 1995; 34: 893-897.
17. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995; 22(6): 696-699.
18. Ordidge RJ, Connelly A, Lohman JAB. Image-selected in vivo spectroscopy (Isis) - a new technique for spatially selective NMR-spectroscopy. J. Magn. Reson. 1986; 66: 283-294.
19. Hamilton G, Patel N, Forton DM, Hajnal JV, Taylor-Robinson SD. Prior knowledge for time domain quantification of in vivo brain or liver P-31 MR spectra. NMR Biomed. 2003; 16: 168-176.
20. 1 with surface coils. J. Magn. Reson. 1983; 53: 52-64.
21. 1H decoupling schemes. Proc. Soc. Magn. Reson. 1992; 3: 3312.
22. van Ormondt D, de Beer R, Marien AJH, den Hollader JA, Luyten PR, Vermeulen JWA. Two-dimensional approach to quantitation of inversion-recovery data. J. Magn. Reson. 1990; 88: 652-659.
23. 31P relaxation in phosphorus metabolites. MAGMA, 1994; 2: 421-423.
24. 31P spin-lattice relaxation times and resonance linewidths of rat tissue in vivo: dependence upon the static magnetic field strength. Magn. Reson. Med. 1985; 2: 410-417.
25. 31P NMR spectra of the human brain in vivo. NMR Biomed. 1994; 7: 237-242.